Aducanumab news could 'open the floodgates' for Alzheimer's drugs- STAT

Aducanumab news could 'open the floodgates' for Alzheimer's drugs- STAT

Biogen’s good news on aducanumab could ‘open the floodgates’ for Alzheimer’s drugs

By DENNIS J. SELKOE

ADOBE

Biogen's positive re-analyses of the aducanumab data represent a key proof of concept: a drug can meaningfully affect clinical symptoms in Alzheimer’s.

READ MORE